Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study

Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study Publisher Pubmed

Shamshiri H¹ ; Fatehi F¹ ; Davoudi F² ; Mir E³ ; Pourmirza B³ ; Abolfazli R¹ ; Etemadifar M⁴ ; Harirchian MH¹ ; Gharagozli K⁵ ; Ayromlou H⁶ ; Basiri K⁴ ; Zamani B⁷ ; Rohani M⁷ ; Sedighi B⁸ Show All Authors

Shamshiri H¹
Fatehi F¹
Davoudi F²
Mir E³
Pourmirza B³
Abolfazli R¹
Etemadifar M⁴
Harirchian MH¹
Gharagozli K⁵
Ayromlou H⁶
Basiri K⁴
Zamani B⁷
Rohani M⁷
Sedighi B⁸
Roudbari A⁹
Delavar Kasmaei H⁵
Nikkhah K¹⁰
Ranjbar Naeini A¹¹
Nafissi S¹

Show Affiliations

1. Iranian Center of Neurological Research, Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Community Medicine, Iran University of Medical Sciences, Tehran, Iran
3. Sanofi-Medical Department, Tehran, Iran
4. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
5. Department of Neurology, Shahid Beheshti Medical University, Tehran, Iran
6. Department of Neurology, Tabriz University of Medical Sciences, Tehran, Iran
7. Department of Neurology, Iran University of Medical Sciences, Tehran, Iran
8. Department of Neurology, Kerman University of Medical Sciences, Kerman, Iran
9. Department of Neurology, Gilan University of Medical Sciences, Tehran, Iran
10. Department of Neurology, Mashhad University of Medical Sciences, Tehran, Iran
11. Aja Medical University, Tehran, Iran

Source: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Published:2015

Abstract

This study was designed to evaluate ALS progression among different subgroups of Iranian patients.Three hundred and fifty-eight patients from centres around the country were registered and their progression rate was evaluated using several scores including Manual Muscle Test scoring (MMT) and the revised ALS Functional Rating Scale (ALSFRS-R). Progression rate was analysed separately in subgroups regarding gender, onset site, stage of disease and riluzole consumption. A significant difference in MMT deterioration rate (p = 0.01) was noted between those who used riluzole and those who did not. No significant difference was observed in progression rates between male/female and bulbar-onset/limb-onset groups using riluzole. In conclusion, riluzole has a significant effect on muscle force deterioration rate but not functional scale. Progression rate was not influenced by site of onset or gender. © 2015 Taylor & Francis.

Related Docs

View other Related Docs

1. Trends of Quality of Life Changes in Amyotrophic Lateral Sclerosis Patients, Journal of the Neurological Sciences (2016)

2. Iranian Clinical Practice Guideline for Amyotrophic Lateral Sclerosis, Frontiers in Neurology (2023)

3. Intraspinal Delivery of Bone Marrow Stromal Cell-Derived Neural Stem Cells in Patients With Amyotrophic Lateral Sclerosis: A Safety and Feasibility Study, Journal of the Neurological Sciences (2016)

4. Safety and Efficacy of Nanocurcumin As Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial, Neurotherapeutics (2018)

5. Granulocyte Colony-Stimulating Factor for Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study of Iranian Patients, Journal of Clinical Neurology (Korea) (2015)

6. Mutation Screening of Slc52a3, C19orf12, and Tardbp in Iranian Als Patients, Neurobiology of Aging (2019)

7. Stratification of Amyotrophic Lateral Sclerosis Patients: A Crowdsourcing Approach, Scientific Reports (2019)

8. Description of Combined Arhsp/Jals Phenotype in Some Patients With Spg11 Mutations, Molecular Genetics and Genomic Medicine (2020)

Experts (# of related papers)

View all Related Experts

Shahriar Nafissi (7)

Farzad Fatehi (3)

Style	Citing Format
MLA	Shamshiri H, et al.. "Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 16, no. 7-8, 2015, pp. 506-511.
APA	Shamshiri H, Fatehi F, Davoudi F, Mir E, Pourmirza B, Abolfazli R, Etemadifar M, Harirchian MH, Gharagozli K, Ayromlou H, Basiri K, Zamani B, Rohani M, Sedighi B, Roudbari A, Delavar Kasmaei H, Nikkhah K, Ranjbar Naeini A, Nafissi S (2015). Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 506-511.
Chicago	Shamshiri H, Fatehi F, Davoudi F, Mir E, Pourmirza B, Abolfazli R, Etemadifar M, et al.. "Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16, no. 7-8 (2015): 506-511.
Harvard	Shamshiri H et al. (2015) 'Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), pp. 506-511.
Vancouver	Shamshiri H, Fatehi F, Davoudi F, Mir E, Pourmirza B, Abolfazli R, et al.. Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2015;16(7-8):506-511.
BibTex	@article{ author = {Shamshiri H and Fatehi F and Davoudi F and Mir E and Pourmirza B and Abolfazli R and Etemadifar M and Harirchian MH and Gharagozli K and Ayromlou H and Basiri K and Zamani B and Rohani M and Sedighi B and Roudbari A and Delavar Kasmaei H and Nikkhah K and Ranjbar Naeini A and Nafissi S}, title = {Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study}, journal = {Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration}, volume = {16}, number = {7-8}, pages = {506-511}, year = {2015} }
RIS	TY - JOUR AU - Shamshiri H AU - Fatehi F AU - Davoudi F AU - Mir E AU - Pourmirza B AU - Abolfazli R AU - Etemadifar M AU - Harirchian MH AU - Gharagozli K AU - Ayromlou H AU - Basiri K AU - Zamani B AU - Rohani M AU - Sedighi B AU - Roudbari A AU - Delavar Kasmaei H AU - Nikkhah K AU - Ranjbar Naeini A AU - Nafissi S TI - Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration VL - 16 IS - 7-8 SP - 506 EP - 511 PY - 2015 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract